These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15481439)

  • 1. Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.
    Galm O; Esteller M
    Int J Hematol; 2004 Aug; 80(2):120-7. PubMed ID: 15481439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fundamental role of epigenetics in hematopoietic malignancies.
    Galm O; Herman JG; Baylin SB
    Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of epigenetic changes in hematological malignancies.
    Lehmann U; Brakensiek K; Kreipe H
    Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of DNA methylation in hematologic malignancies.
    Rush LJ; Plass C
    Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg.
    Esteller M
    Clin Immunol; 2003 Oct; 109(1):80-8. PubMed ID: 14585279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances of research on demethylation therapy for hematologic malignancies].
    Chen CH; Yang JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1394-8. PubMed ID: 19840491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.
    Kinoshita T
    Int J Hematol; 2004 Aug; 80(2):108-19. PubMed ID: 15481438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation and cancer therapy: new developments and expectations.
    Esteller M
    Curr Opin Oncol; 2005 Jan; 17(1):55-60. PubMed ID: 15608514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DNA methylation landscape of hematological malignancies: an update.
    Blecua P; Martinez-Verbo L; Esteller M
    Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies.
    Fraga MF; Berdasco M; Ballestar E; Ropero S; Lopez-Nieva P; Lopez-Serra L; Martín-Subero JI; Calasanz MJ; Lopez de Silanes I; Setien F; Casado S; Fernandez AF; Siebert R; Stifani S; Esteller M
    Cancer Res; 2008 Jun; 68(11):4116-22. PubMed ID: 18519670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic modulation in hematologic malignancies: challenges and progress.
    Mitsiades CS; Anderson KC
    J Natl Compr Canc Netw; 2009 Nov; 7 Suppl 8():S1-12; quiz S14-6. PubMed ID: 19930971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
    van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
    Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in Hematological Malignancies.
    Cruz-Rodriguez N; Combita AL; Zabaleta J
    Methods Mol Biol; 2018; 1856():87-101. PubMed ID: 30178247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.